Senseonics Holdings, Inc. (SENS)
NYSEAMERICAN: SENS · Real-Time Price · USD
0.4475
-0.0016 (-0.36%)
At close: Sep 17, 2025, 4:00 PM EDT
0.4480
+0.0005 (0.11%)
Pre-market: Sep 18, 2025, 9:16 AM EDT
Senseonics Holdings Revenue
Senseonics Holdings had revenue of $6.65M in the quarter ending June 30, 2025, with 36.67% growth. This brings the company's revenue in the last twelve months to $25.47M, up 5.94% year-over-year. In the year 2024, Senseonics Holdings had annual revenue of $22.47M with 0.37% growth.
Revenue (ttm)
$25.47M
Revenue Growth
+5.94%
P/S Ratio
12.39
Revenue / Employee
$217,658
Employees
117
Market Cap
364.57M
Revenue Chart
Revenue History
| Fiscal Year End | Revenue | Change | Growth |
|---|---|---|---|
| Dec 31, 2024 | 22.47M | 82.00K | 0.37% |
| Dec 31, 2023 | 22.39M | 6.00M | 36.62% |
| Dec 31, 2022 | 16.39M | 2.71M | 19.85% |
| Dec 31, 2021 | 13.68M | 8.73M | 176.32% |
| Dec 31, 2020 | 4.95M | -16.35M | -76.77% |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2017 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2016 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2015 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Sources: Historical revenue is based on company filings submitted to the U.S. Securities and Exchange Commission (SEC). The most recent revenue numbers may be taken from company press releases.
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
| Company Name | Revenue |
|---|---|
| UnitedHealth Group | 422.82B |
| Johnson & Johnson | 90.63B |
| Merck & Co. | 63.62B |
| AbbVie | 58.33B |
| AstraZeneca | 56.50B |
| Novartis AG | 55.19B |
| Eli Lilly and Company | 53.26B |
| Novo Nordisk | 49.11B |
SENS News
- 13 days ago - Senseonics Holdings, Inc. (SENS) Eversense 365 Commercial Update Call (Transcript) - Seeking Alpha
- 14 days ago - Ascensia Diabetes Care Signs MOU to Transfer Eversense® CGM Distribution to Strategic Partner Senseonics - Business Wire
- 14 days ago - Senseonics Signs Memorandum of Understanding with Ascensia Diabetes Care to Take Over Commercialization and Distribution of Eversense 365 - GlobeNewsWire
- 6 weeks ago - Senseonics Holdings, Inc. (SENS) Q2 2025 Earnings Call Transcript - Seeking Alpha
- 6 weeks ago - Senseonics Holdings, Inc. Reports Second Quarter Financial Results - GlobeNewsWire
- 2 months ago - Senseonics Holdings, Inc. Schedules Second Quarter 2025 Earnings Release and Conference Call for August 6, 2025 at 4:30 P.M. Eastern Time - GlobeNewsWire
- 3 months ago - Senseonics Holdings, Inc. to Host In-Person and Virtual Analyst Event at ADA 2025: Eversense® 365 Continuous Glucose Monitoring System for People with Diabetes - GlobeNewsWire
- 4 months ago - Senseonics Holdings, Inc. Announces Closing of Public Offering, Including Exercise in Full of the Underwriters' Option to Purchase Additional Shares, and Closing of Private Placement - GlobeNewsWire